Results 71 to 80 of about 5,120,986 (304)

Evaluation of coagulation disorders and iron deficiency in women with heavy menstrual bleeding

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To explore the incidence of congenital bleeding disorders (CBD), which may result in anemia, in a large cohort of women referred for heavy menstrual bleeding (HMB) in a specialized gynecologic unit. Methods Between January 2022 and January 2024, all women referred for HMB were screened.
Lucia Rugeri, Yelena Fruchou, Caroline Brodbeck, Marianne Bastien, Amandine Lioux, Giulia Gouy, Marion Cortet, Gil Dubernard, Yesim Dargaud   +8 more
wiley   +1 more source

The efficacy and safety of intravenous tranexamic acid in patients with posterior operation of multilevel thoracic spine stenosis: a prospective randomized controlled trial

BMC Musculoskeletal Disorders, 2022
Background This study was a randomized controlled trial to evaluate efficacy and safety of the usage of intravenous tranexamic acid during posterior operation of multilevel thoracic spine stenosis for controlling perioperative blood loss.
Tan Lei, Wen Bingtao, Guo Zhaoqing, Chen Zhongqiang, Liu Xin   +4 more
doaj   +1 more source

Management of dental extraction in patients with Haemophilia A and B: a report of 58 extractions [PDF]

, 2014
Objectives: Patients with inherited bleeding disorders are at high risk of bleeding following oral surgery and present challenges to the oral surgeons. Aim of this study was to report our experience in dental extraction in patients exhibiting Haemophilia
Peisker, Andre, Raschke, Gregor-Franziskus, Schultze Mosgau, Stefan   +2 more
core   +1 more source

Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.

Health Technology Assessment, 2021
BACKGROUND Tranexamic acid safely reduces mortality in traumatic extracranial bleeding. Intracranial bleeding is common after traumatic brain injury and can cause brain herniation and death.
I. Roberts, H. Shakur-Still, A. Aeron-Thomas, D. Beaumont, A. Belli, A. Brenner, Madeleine Cargill, R. Chaudhri, N. Douglas, Lauren Frimley, Catherine Gilliam, A. Geer, Z. Jamal, R. Jooma, Raoul Mansukhani, A. Miners, J. Pott, D. Prowse, T. Shokunbi, Jack Williams   +19 more
semanticscholar   +1 more source

Protective effect of rooming‐in on postpartum hemorrhage: A propensity score analysis

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study investigates the effect of rooming‐in on postpartum hemorrhage (PPH) and other adverse maternal postpartum outcomes. Methods A retrospective study was performed on all healthy women with singleton term pregnancies at a tertiary medical center between 2013 and 2022.
Natav Hendin, Yossi Geron, Ran Matot, Shiran Loewenstein, Eran Hadar, Asnat Walfisch, Rony Chen, Ohad Houri   +7 more
wiley   +1 more source

Use of tranexamic acid for skin whitening and melasma therapy: A product review

Archives of Pharmacy Practice, 2016
Purpose: The aim of this study is to assess the usage of tranexamic acid as skin whitening and melasma therapy. Methodology: An electronic search on PubMed, MEDLINE and Cochrane Library with keywords “tranexamic acid,” “oral,” “systemic,” “whitening ...
Halimi Syafiqah Nadiah, Masood Hannah, Kah Seng Lee, Suhaidah Mohd Jofrry, Long Chiau Ming   +4 more
doaj   +1 more source

Correction to "Randomized Clinical Trial on the Efficacy of Oral Tranexamic Acid Versus Topical Tranexamic Acid in Treatment of Melasma". [PDF]

J Cosmet Dermatol
Journal of Cosmetic Dermatology, Volume 24, Issue 11, November 2025.
europepmc   +2 more sources

Tranexamic acid for chronic subdural hematoma

British Journal of Neurosurgery, 2021
Background There is no consensus on optimal treatment for a chronic subdural hematoma (cSDH). In patients with only moderate symptoms treatment with tranexamic acid (TXA) has been suggested. We report off-label use of TXA in seven patients.
R. Lodewijkx, S. Immenga, R. van den Berg, R. Post, Lucas G. Westerink, R. Nabuurs, Anil Can, W. Vandertop, D. Verbaan   +8 more
semanticscholar   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox, Rosinder Kaur, Kugajeevan Vigneswaran, Rachel Small, Jenny Carter, Keelin O'Donoghue, Alexander E. P. Heazell, Anna L. David, Nigel Simpson, Angharad Care, Lisa Starrs, Andrew Shennan, Catalina María Valencia González, Priya Soma‐Pillay, Leah Fitzsimmons, Adam J. Devall, Arri Coomarasamy, Mid‐trimester Pregnancy Loss Guideline Consensus Panel, Owen Arthurs, Ruth Bender‐Atik, Phil Bennett, Kirstien Boelaert, Elizabeth Bonney, Leanna Brace, Naomi Carlisle, Davide Casagrandi, Manju Chandiramani, Carolyn Chiswick, Alexandra Emms, Stella Fielder, James Goadsby, Laura Goodfellow, Jim Gray, Jemma Johns, Emma Kirk, Will Lester, Sophie Mackay, Maria Memtsa, Katie Morris, Sunbal Mukhtar, Naimah Raza, Rita Sarquis, Neil Sebire, Lucy Smith, Lucy Spencer, Amos Tetteh, Natalie Woodhead   +46 more
wiley   +1 more source

Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms. [PDF]

, 2017
BACKGROUND: The CRASH-2 trial showed that tranexamic acid (TXA) administration reduces mortality in bleeding trauma patients. However, the effect appeared to depend on how soon after injury TXA treatment was started. Treatment within 3 h reduced bleeding
Edwards, Phil, Joshi, Miland, Ker, Katharine, Mahmood, Abda, Prieto, David, Roberts, Ian, Shakur, Haleema   +6 more
core   +6 more sources